Poll

POLL: Will you use biosimilars in your ophthalmic practice?

Author(s):

Sheryl Stevenson

Let us know if you will plan to use biosimilars in your daily practice. The poll will be open until October 10, 2022.

Will you use biosimilars in your ophthalmic practice?

Yes, I plan to use biosimilars in my practice
No, I do not plan to use biosimilars in my practice

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
Related Content
Aldeyra Therapeutics receives orphan designation for ADX-2191 from EMA
July 26th 2025

Aldeyra Therapeutics receives orphan designation for ADX-2191 from EMA

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Kiora Pharmaceuticals Secures US Patent for KIO-104
July 24th 2025

Kiora Pharmaceuticals Secures US Patent for KIO-104

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Researchers explore ChatGPT4o's ability to generate realistic retinal fundus images
July 22nd 2025

Researchers explore ChatGPT4o's ability to generate realistic retinal fundus images

Role of mucormycosis infection on vision in diabetic patient
July 22nd 2025

Role of mucormycosis infection on vision in diabetic patient

© 2025 MJH Life Sciences

All rights reserved.